vs
CENTERSPACE（CSR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
CENTERSPACE的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.9倍（$66.6M vs $35.5M），CENTERSPACE净利率更高（-27.7% vs -304.2%，领先276.6%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 0.3%），CENTERSPACE自由现金流更多（$64.3M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 1.6%）
Centerspace是一家专注于多户住宅物业持有、运营与开发的房地产投资企业，核心业务覆盖美国中西部及落基山西部区域，面向不同租户群体提供经济型及高端住宅选择，重视租户体验与资产长期价值增长。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CSR vs RXRX — 直观对比
营收规模更大
CSR
是对方的1.9倍
$35.5M
营收增速更快
RXRX
高出681.4%
0.3%
净利率更高
CSR
高出276.6%
-304.2%
自由现金流更多
CSR
多$111.6M
$-47.3M
两年增速更快
RXRX
近两年复合增速
1.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.6M | $35.5M |
| 净利润 | $-18.4M | $-108.1M |
| 毛利率 | 96.5% | 59.8% |
| 营业利润率 | -15.9% | -304.8% |
| 净利率 | -27.7% | -304.2% |
| 营收同比 | 0.3% | 681.7% |
| 净利润同比 | -262.9% | 39.6% |
| 每股收益（稀释后） | $-1.08 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSRRXRX
| Q4 25 | $66.6M | $35.5M | ||
| Q3 25 | $71.4M | $5.2M | ||
| Q2 25 | $68.5M | $19.2M | ||
| Q1 25 | $67.1M | $14.7M | ||
| Q4 24 | $66.4M | $4.5M | ||
| Q3 24 | $65.0M | $26.1M | ||
| Q2 24 | $65.0M | $14.4M | ||
| Q1 24 | $64.5M | $13.8M |
净利润CSRRXRX
| Q4 25 | $-18.4M | $-108.1M | ||
| Q3 25 | $53.8M | $-162.3M | ||
| Q2 25 | $-14.5M | $-171.9M | ||
| Q1 25 | $-3.7M | $-202.5M | ||
| Q4 24 | $-5.1M | $-178.9M | ||
| Q3 24 | $-1.0M | $-95.8M | ||
| Q2 24 | $-1.3M | $-97.5M | ||
| Q1 24 | $-3.9M | $-91.4M |
毛利率CSRRXRX
| Q4 25 | 96.5% | 59.8% | ||
| Q3 25 | 96.5% | -183.8% | ||
| Q2 25 | 96.5% | -4.9% | ||
| Q1 25 | 96.4% | -48.0% | ||
| Q4 24 | 96.5% | -181.4% | ||
| Q3 24 | 96.6% | 53.7% | ||
| Q2 24 | 96.6% | 36.2% | ||
| Q1 24 | 96.4% | 19.1% |
营业利润率CSRRXRX
| Q4 25 | -15.9% | -304.8% | ||
| Q3 25 | — | -3327.6% | ||
| Q2 25 | -9.9% | -916.8% | ||
| Q1 25 | 7.1% | -1297.9% | ||
| Q4 24 | 4.3% | -4042.4% | ||
| Q3 24 | 9.8% | -377.1% | ||
| Q2 24 | 11.1% | -697.4% | ||
| Q1 24 | 6.3% | -698.4% |
净利率CSRRXRX
| Q4 25 | -27.7% | -304.2% | ||
| Q3 25 | 75.3% | -3135.3% | ||
| Q2 25 | -21.2% | -894.2% | ||
| Q1 25 | -5.6% | -1373.3% | ||
| Q4 24 | -7.6% | -3935.5% | ||
| Q3 24 | -1.6% | -367.5% | ||
| Q2 24 | -2.0% | -676.6% | ||
| Q1 24 | -6.1% | -662.4% |
每股收益（稀释后）CSRRXRX
| Q4 25 | $-1.08 | $-0.17 | ||
| Q3 25 | $3.19 | $-0.36 | ||
| Q2 25 | $-0.87 | $-0.41 | ||
| Q1 25 | $-0.22 | $-0.50 | ||
| Q4 24 | $-0.31 | $-0.56 | ||
| Q3 24 | $-0.40 | $-0.34 | ||
| Q2 24 | $-0.19 | $-0.40 | ||
| Q1 24 | $-0.37 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.8M | $743.3M |
| 总债务越低越好 | $1.0B | $9.6M |
| 股东权益账面价值 | $719.2M | $1.1B |
| 总资产 | $1.9B | $1.5B |
| 负债/权益比越低杠杆越低 | 1.42× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资CSRRXRX
| Q4 25 | $12.8M | $743.3M | ||
| Q3 25 | $12.9M | $659.8M | ||
| Q2 25 | $12.4M | $525.1M | ||
| Q1 25 | $11.9M | $500.5M | ||
| Q4 24 | $12.0M | $594.4M | ||
| Q3 24 | $14.5M | $427.6M | ||
| Q2 24 | $14.3M | $474.3M | ||
| Q1 24 | $12.7M | $296.3M |
总债务CSRRXRX
| Q4 25 | $1.0B | $9.6M | ||
| Q3 25 | $1.1B | $11.9M | ||
| Q2 25 | $1.1B | $14.2M | ||
| Q1 25 | $955.5M | $16.4M | ||
| Q4 24 | $955.4M | $19.0M | ||
| Q3 24 | $921.3M | $20.5M | ||
| Q2 24 | $931.7M | $22.9M | ||
| Q1 24 | $929.1M | — |
股东权益CSRRXRX
| Q4 25 | $719.2M | $1.1B | ||
| Q3 25 | $748.6M | $1.0B | ||
| Q2 25 | $710.1M | $919.1M | ||
| Q1 25 | $636.8M | $933.9M | ||
| Q4 24 | $752.0M | $1.0B | ||
| Q3 24 | $672.5M | $524.6M | ||
| Q2 24 | $680.7M | $584.4M | ||
| Q1 24 | $688.1M | $401.2M |
总资产CSRRXRX
| Q4 25 | $1.9B | $1.5B | ||
| Q3 25 | $2.1B | $1.4B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $1.9B | $1.4B | ||
| Q3 24 | $1.9B | $726.5M | ||
| Q2 24 | $1.9B | $775.9M | ||
| Q1 24 | $1.9B | $557.8M |
负债/权益比CSRRXRX
| Q4 25 | 1.42× | 0.01× | ||
| Q3 25 | 1.53× | 0.01× | ||
| Q2 25 | 1.57× | 0.02× | ||
| Q1 25 | 1.50× | 0.02× | ||
| Q4 24 | 1.27× | 0.02× | ||
| Q3 24 | 1.37× | 0.04× | ||
| Q2 24 | 1.37× | 0.04× | ||
| Q1 24 | 1.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.5M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $64.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | 96.5% | -133.1% |
| 资本支出强度资本支出/营收 | 51.3% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $125.9M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流CSRRXRX
| Q4 25 | $98.5M | $-46.1M | ||
| Q3 25 | $35.1M | $-117.4M | ||
| Q2 25 | $25.3M | $-76.4M | ||
| Q1 25 | $25.4M | $-132.0M | ||
| Q4 24 | $98.2M | $-115.4M | ||
| Q3 24 | $32.3M | $-59.2M | ||
| Q2 24 | $22.9M | $-82.2M | ||
| Q1 24 | $24.4M | $-102.3M |
自由现金流CSRRXRX
| Q4 25 | $64.3M | $-47.3M | ||
| Q3 25 | $25.7M | $-117.6M | ||
| Q2 25 | $15.5M | $-79.6M | ||
| Q1 25 | $20.4M | $-133.8M | ||
| Q4 24 | $41.6M | $-116.7M | ||
| Q3 24 | $20.5M | $-63.8M | ||
| Q2 24 | $9.1M | $-83.4M | ||
| Q1 24 | $2.6M | $-109.0M |
自由现金流率CSRRXRX
| Q4 25 | 96.5% | -133.1% | ||
| Q3 25 | 36.0% | -2272.5% | ||
| Q2 25 | 22.7% | -413.9% | ||
| Q1 25 | 30.4% | -907.4% | ||
| Q4 24 | 62.6% | -2567.7% | ||
| Q3 24 | 31.5% | -244.6% | ||
| Q2 24 | 14.0% | -578.5% | ||
| Q1 24 | 4.0% | -789.9% |
资本支出强度CSRRXRX
| Q4 25 | 51.3% | 3.5% | ||
| Q3 25 | 13.1% | 4.7% | ||
| Q2 25 | 14.2% | 16.4% | ||
| Q1 25 | 7.5% | 12.4% | ||
| Q4 24 | 85.3% | 28.6% | ||
| Q3 24 | 18.2% | 17.5% | ||
| Q2 24 | 21.2% | 8.2% | ||
| Q1 24 | 33.8% | 48.2% |
现金转化率CSRRXRX
| Q4 25 | — | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSR
| Multi Family Residential | $57.3M | 86% |
| Other | $8.1M | 12% |
| Other Property Revenue | $1.2M | 2% |
RXRX
暂无分部数据
